Showing results (41-50 of 107) with videos related to

Sort By:
Pageof 11
Clinical Lung Cancer|December 31, 2014
Should Tyrosine Kinase Inhibitors Be Considered for Advanced Non-Small-Cell Lung Cancer Patients With Wild Type EGFR? Two Systematic Reviews and Meta-Analyses of Randomized TrialsClaire L Vale, Sarah Burdett, David J Fisher, et al.
BMJ Open|September 9, 2017
Patient experience and perceived acceptability of whole-body magnetic resonance imaging for staging colorectal and lung cancer compared with current staging scans: a qualitative studyRuth Evans, Stuart Taylor, Sam Janes, et al.
BMJ Oncology|May 28, 2026
Utilisation patterns of systemic anticancer therapy (SACT) in patients with advanced non-small cell lung cancer (NSCLC) in EnglandLauren Kari Dixon, Adrian Cook, Sarah Cook, et al.
The Oncologist|November 4, 2020
Navigating Diagnostic and Treatment Decisions in Non-Small Cell Lung Cancer: Expert Commentary on the Multidisciplinary Team ApproachSanjay Popat, Neal Navani, Keith M Kerr, et al.
Translational Lung Cancer Research|November 7, 2024
Systems mapping: a novel approach to national lung cancer screening implementation in AustraliaSandra Marjanovic, Andrew Page, Emily Stone, et al.
BMC Cancer|January 29, 2020
Comorbidity prevalence among cancer patients: a population-based cohort study of four cancersHelen Fowler, Aurelien Belot, Libby Ellis, et al.
Breathe (Sheffield, England)|July 17, 2025
Mediastinal staging of nonsmall cell lung cancer: what's new?Claire Bradley, Nuria Novoa, Laura Riva, et al.
Nuclear Medicine Communications|September 14, 2023
PET/CT in treatment response assessment in lung cancer. When should it be recommended?Noora Bin Essa, Zoltan Kaplar, Nikita Balaji, et al.
Ebiomedicine|March 20, 2026
Multidisciplinary international expert consensus recommendations on tissue acquisition in non-small cell lung cancerPyng Lee, Karim Abdelhamid, Rachel Butler, et al.
BMC Cancer|April 22, 2016
The Lung Screen Uptake Trial (LSUT): protocol for a randomised controlled demonstration lung cancer screening pilot testing a targeted invitation strategy for high risk and 'hard-to-reach' patientsSamantha L Quaife, Mamta Ruparel, Rebecca J Beeken, et al.
Pageof 11